Exponent CEO Catherine Corrigan sells $113,135 in EXPO shares
Exponent CEO Catherine Corrigan sold 1,707 shares of EXPO stock for $113,135 to cover stock option exercise costs and taxes, while simultaneously exercising options to acquire 2,379 shares. Post-transaction, she directly holds 129,108 shares. This comes after Exponent reported strong Q2 2026 results, exceeding expectations and raising its full-year outlook.
Exponent CEO Catherine Corrigan disposes of 1,707 shares worth $113,144 in Exponent stock
Exponent CEO Catherine Corrigan sold 1,707 shares of Exponent stock for $113,144 on August 17, after exercising non-qualified stock options for 2,379 shares at $29.05 on the same day. This transaction leaves her with 129,108 shares owned in the company. The information was generated by AI based on an EDGAR filing from Exponent Inc.
Exponent (NASDAQ: EXPO) CEO trades shares tied to option exercise
Exponent Inc. (NASDAQ: EXPO) CEO Catherine Corrigan exercised 2,379 non-qualified stock options at $29.05 per share and subsequently sold 1,707 common shares at $66.2776 per share. The sale, conducted under a Rule 10b5-1 trading plan, was intended to cover the option exercise price and associated taxes. Following these transactions, Corrigan holds 129,108 common shares directly.
Exponent CEO Catherine Corrigan disposes of 1,707 shares worth $113,144 in Exponent stock
Exponent CEO Catherine Corrigan sold 1,707 shares of Exponent stock for $113,144 on August 17. Earlier, she exercised non-qualified stock options for 2,379 shares. After these transactions, she retains 129,108 shares in the company.
Exponent (NASDAQ: EXPO) insider to sell 1,707 shares
An insider at Exponent, Inc. (EXPO) plans to sell 1,707 shares of common stock, stemming from an exercise of stock options on August 17, 2026. The transaction will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services and has an aggregate value of $114,539.70. This filing also references prior 10b5-1 sales by Catherine Corrigan in June and July 2026.
ETFs Investing in Exponent, Inc. Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Exponent, Inc. stocks, sorted by market value. It details various ETFs, including their market value, weight of Exponent, Inc. stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, and 3-year NAV total return. The information aims to help investors explore opportunities to invest in Exponent, Inc. indirectly through diversified ETF portfolios.
Assenagon Asset Management S.A. Makes New $2.31 Million Investment in Exponent, Inc. $EXPO
Assenagon Asset Management S.A. has initiated a new position in Exponent, Inc. (NASDAQ:EXPO), investing approximately $2.31 million by purchasing 39,342 shares. Exponent recently exceeded quarterly earnings expectations with $0.60 EPS on $171.61 million revenue, and declared a quarterly dividend of $0.31 per share. The stock currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $81.
Exponent Inc (EXPO) Earnings Forecast: Future EPS & Revenue Growth Estimates
Exponent Inc (EXPO) has an earnings forecast score of 8.00, placing it 38th in its industry. Analysts have set an average price target of $83.00, with a high of $90.00 and a low of $76.00, predominantly recommending a "Buy" for the stock. The company's expected revenue for the next quarter is $152.69 million, and its EPS for the next quarter is projected to be $0.59.
Quantinno Capital Management LP Acquires 19,528 Shares of Exponent, Inc. $EXPO
Quantinno Capital Management LP significantly increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 114.3% in Q1, purchasing 19,528 additional shares, bringing its total holding to $2.39 million. Other institutional investors also adjusted their positions in Exponent, a company with strong institutional ownership (92.37%). Exponent reported solid Q1 earnings, exceeding estimates with $0.60 EPS and 12% year-over-year revenue growth, and declared a quarterly dividend of $0.31 per share.
Exponent, Inc. (EXPO) Stock Forecasts
Argus has raised its target price for Exponent, Inc. (EXPO), a science and engineering consulting firm, to $71.00. The report highlights Exponent's team of scientists, physicians, engineers, and business consultants who provide solutions to complex problems. The current stock price for EXPO is $67.52.
Exponent (EXPO) Q2 2026 Earnings Call Transcript
Exponent (EXPO) reported strong Q2 2026 results with double-digit growth in revenues and earnings, driven by increased demand for specialized expertise, particularly in user research studies for AI-enabled products and risk management in the utility sector. The company raised its full-year 2026 revenue and EBITDA guidance, reflecting confidence in ongoing market trends and project expansion. Exponent also actively repurchased shares and highlighted its competitive advantage in multidisciplinary scientific and engineering consulting for complex, high-consequence challenges.
How Investors May Respond To Exponent (EXPO) Upgraded 2026 Guidance And Expanded Buyback Plan
Exponent (EXPO) recently reported strong Q2 2026 results with year-on-year growth in sales, revenue, and net income, along with a dividend declaration and share repurchase completion. The company also upgraded its 2026 revenue growth guidance to 9-10% and expanded its share buyback authorization by US$50 million to US$836.7 million. This signals management's confidence and continued focus on capital return, although investors should remain aware of potential risks like utilization and staffing efficiency.
How Investors May Respond To Exponent (EXPO) Upgraded 2026 Guidance And Expanded Buyback Plan
Exponent, Inc. recently reported strong Q2 2026 results, showing significant year-on-year growth in sales, revenue, and net income, along with a dividend declaration and share repurchase completion. The company also upgraded its 2026 revenue growth guidance to 9% to 10% and expanded its share buyback authorization, indicating management's confidence and focus on capital returns. This upgraded guidance is expected to influence the investment narrative around Exponent's growth and resilience, despite ongoing risks related to utilization and workforce efficiency.
EXPO SEC Filings - EXPONENT INC 10-K, 10-Q, 8-K Forms
This article provides a comprehensive overview of EXPONENT INC (EXPO) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading disclosures. It highlights recent filings from July and August 2026, detailing the company's strong Q2 2026 financial results with significant revenue growth driven by AI-related projects, CEO option exercises and stock sales, shareholder meeting results, and dividend declarations. The page also offers various tools and rankings related to EXPO stock.
How Investors May Respond To Exponent (EXPO) Upgraded 2026 Guidance And Expanded Buyback Plan
Exponent (EXPO) recently reported strong Q2 2026 results, including increased sales, revenue, and net income, along with an expanded share buyback plan and a confirmed dividend. The company also raised its 2026 revenue growth guidance to 9-10%, signaling management's confidence and focus on capital return. This positive update reinforces Exponent's investment narrative around growth and resilience, though investors should still consider risks related to utilization and staffing efficiency.
EXPONENT INC Q2 2026: Revenue $171.6M, EPS $0.6— 10-Q Summary
Exponent Inc (EXPO) reported strong second-quarter 2026 results, with revenue reaching $171.6 million, a 20.9% increase year-over-year. Diluted earnings per share rose to $0.60, up from $0.52 in Q2 2025, while net income grew by 10.8% to $29.4 million. The company attributed this growth to higher billable hours, increased billing rates, and a strategic shift towards proactive user research and AI-enabled product studies.
Exponent Inc (EXPO) Stock News Today
This article provides current stock news for Exponent Inc (EXPO), including its stock performance and market capitalization. It highlights that more news is expected soon and directs users to various sections like news & analysis, financials, and analyst ratings.
Renaissance Technologies LLC Makes New Investment in Exponent, Inc. $EXPO
Renaissance Technologies LLC has acquired a new stake of 88,000 shares in Exponent, Inc. (NASDAQ:EXPO), valued at $5.7 million, as institutional investors now own 92.37% of the company. Analysts have a "Moderate Buy" consensus rating with a target price of $81, following Exponent's strong Q1 earnings of $0.60 per share and $171.61 million in revenue. The company also declared a quarterly dividend of $0.31 per share.
Exponent Stock And Two Legal Services Picks For Tariff Driven Demand
The article highlights Exponent (EXPO), Mastech Digital (MHH), and Jacobs Solutions (J) as three stocks poised to benefit from increased demand for legal services, litigation support, and compliance advice due to new global tariffs. It details each company's operations, market cap, and how their services align with the current regulatory and economic climate, offering investors insights into potential opportunities and risks within the legal and regulatory support sector.
Dimensional Fund Advisors LP Buys 20,270 Shares of Exponent, Inc. $EXPO
Dimensional Fund Advisors LP increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 2.3%, purchasing 20,270 shares to hold a total of 918,885 shares valued at approximately $60 million. The company reported strong Q2 earnings and revenue, exceeding analyst expectations, and raised its 2026 revenue-growth outlook to 9%-10% due to AI-related demand. Despite positive analyst ratings and a declared dividend, insider trading data shows more sales than purchases, raising a "modest sentiment concern."
Exponent (EXPO) Is Up 7.7% After Raising Guidance And Expanding Buybacks Has The Bull Case Changed?
Exponent, Inc. recently reported strong Q2 2026 results, with sales of US$148.86 million and a significant increase in net income to US$29.4 million, driven by demand for AI-related consulting. The company also expanded its share buyback program to US$836.7 million, signaling management's commitment to returning capital to shareholders. This positive financial performance and capital allocation strategy have led to increased full-year guidance and are reshaping the investment narrative for Exponent.
Exponent, Inc. Q2 2026 Earnings Call Summary
Exponent, Inc. reported strong Q2 2026 earnings, primarily driven by proactive user research in AI-enabled hardware and reactive work in transportation and utility sectors. The company raised its full-year guidance due to sustained demand for AI-related work and infrastructure risk management, emphasizing its competitive advantage in complex, bespoke scientific methodologies. Management highlighted increased G&A expenses due to recruiting and a moderated pace for future share repurchases after significant buybacks.
Exponent Inc (EXPO) Stock Up 3.5% and Still Undervalued -- GF Score
Exponent Inc (EXPO) shares recently rose 3.5% to $66.85, yet the stock is considered undervalued by GuruFocus with a GF Value™ estimate of $92.52, suggesting a 27.7% margin of safety. Despite a strong GF Score™ of 87/100, driven by excellent growth and profitability, significant insider selling activity raises cautionary flags for potential investors, highlighting the need for thorough due diligence. The current P/E ratio is also substantially lower than its historical average, further reinforcing the undervaluation.
Exponent (EXPO) Is Up 7.7% After Raising Guidance And Expanding Buybacks Has The Bull Case Changed?
Exponent (EXPO) has seen a 7.7% increase after reporting strong Q2 2026 results, raising full-year guidance, and expanding its share buyback program to $836.7 million. These strategic moves, coupled with demand for AI-related consulting, aim to enhance per-share metrics and return capital to shareholders. The article discusses how these developments reshape the investment narrative for the science and engineering consulting firm.
Earnings call transcript: Exponent tops Q2 2026 estimates, shares edge higher
Exponent (EXPO) surpassed analyst estimates for Q2 2026 with earnings of $0.60 per share and revenue of $171.6 million, leading to a 1.9% rise in after-hours trading. The strong performance was driven by increased demand for user research in AI-enabled products, resulting in an 11% increase in net income and a raised full-year net revenue outlook of 9%-10%. Management highlighted the growing complexity of human-machine interaction in AI-driven physical products and the company's unique multidisciplinary expertise in addressing these challenges.
Exponent (NASDAQ:EXPO) Jumps After Q2 Earnings Beat and Raised Guidance Offset Slight Revenue Miss
Exponent (NASDAQ:EXPO) reported a mixed second quarter with a significant earnings beat and raised full-year guidance, which led to a positive after-market reaction despite a slight revenue miss. The company's EPS of $0.60 exceeded estimates by 7%, while revenues before reimbursements were $148.9 million, slightly below the $150.5 million estimate. Management's increased full-year revenue growth outlook to 9%-10% and a declared quarterly dividend of $0.31 per share further bolstered investor confidence.
Earnings call transcript: Exponent tops Q2 2026 estimates, shares edge higher
Exponent reported stronger-than-expected Q2 2026 results, surpassing earnings and revenue estimates significantly, driven by strong demand in user research studies related to AI-enabled products. The company raised its full-year net revenue outlook and saw its share price rise in after-hours trading. Management highlighted the increasing complexity and multidisciplinary nature of their work, particularly in areas integrating AI into physical products and systems.
Exponent (EXPO) Releases Q2 2026 Earnings: Revenue Rises 20.9% and EPS Beats Estimates
Exponent (EXPO) reported strong Q2 2026 earnings, with revenue increasing by 20.9% year-over-year to $171.6 million and diluted EPS of $0.60, both exceeding analyst estimates. The company also saw a significant rise in operating profit by 63.1% to $28.0 million and net income climbed 10.7% to $29.4 million. The report also detailed insider trading activity, hedge fund movements, government contracts, and analyst price targets for EXPO.
Exponent: Q2 Earnings Snapshot
Exponent Inc. (EXPO) reported its second-quarter earnings, with net income reaching $29.4 million. The company achieved a profit of 60 cents per share and posted revenue of $171.6 million, with an adjusted revenue of $148.9 million. This financial snapshot was generated using data from Zacks Investment Research.
Earnings Flash (EXPO) Exponent, Inc. Reports Q2 Revenue $171.6M, vs. FactSet Est of $145.0M
Exponent, Inc. (EXPO) reported its Q2 revenue at $171.6 million, significantly exceeding the FactSet estimate of $145.0 million. This financial update indicates a strong performance for the science and engineering consulting firm in its second fiscal quarter. The article also mentions recent analyst rating adjustments and other corporate news for Exponent.
Exponent shareholders of record Sept. 4 will receive $0.31 on Sept. 18
Exponent (NASDAQ: EXPO) has declared a Q3 2026 cash dividend of $0.31 per share, payable on September 18, 2026, to shareholders of record as of September 4, 2026. The company's Board of Directors also increased its share repurchase authorization by $50 million, reflecting its commitment to returning capital to shareholders while investing in long-term growth. Exponent anticipates continuing quarterly dividends in March, June, September, and December, subject to future Board determinations.
Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million
Exponent, Inc. announced a regular quarterly cash dividend of $0.31 per share for Q3 2026, payable on September 18, 2026, to stockholders of record as of September 4, 2026. The company also increased its stock repurchase authorization by $50 million, reflecting its strong financial foundation and commitment to returning capital to shareholders while investing in long-term growth.
Exponent earnings up next: Can AI work sustain growth momentum?
Exponent Inc. is set to report its second-quarter fiscal 2026 results, with analysts expecting 55 cents per share on revenue of $145.0 million. The market will be watching whether demand for the company's AI-driven product development and infrastructure work can sustain growth, particularly after a strong first quarter. Concerns about margin trajectory and cost pressures persist, despite a generally bullish outlook from Wall Street.
Exponent: Q2 Earnings Snapshot
Exponent Inc. (EXPO) reported a net income of $29.4 million in its second quarter, translating to 60 cents per share. The engineering and scientific consulting company posted revenues of $171.6 million, with adjusted revenue reaching $148.9 million. The report was generated by Automated Insights using data from Zacks Investment Research.
Exponent Inc (EXPO) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Exponent Inc (EXPO), highlighting its current score of 9.09, which ranks it 17th out of 159 companies in the Professional & Commercial Services industry. The assessment details the company's beta value, indicating it tends to be less volatile than the S&P 500, and includes various metrics such as VaR, maximum drawdown, volatility, and Sharpe Ratio across different timeframes. The U.S. Dollar Index's neutral state is noted to have a neutral effect on the domestic-focused industry.
Exponent Number of Employees 2026 | Employee Count & Headcount Data
Exponent, Inc. (EXPO) had approximately 1,266 employees worldwide as of March 2026, marking a 3.3% growth from 2023. The company is actively hiring, with 389 active job postings in 2026, and its workforce is primarily concentrated in the United States. Exponent's average employee salary is $153,751 globally, and its largest functional groups are Finance and Operations, Engineering, and Sales and Marketing.
Exponent Inc (EXPO) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Exponent Inc (EXPO), listing its major institutional holders and their respective proportions. It also breaks down shareholder types, provides a history of institutional shareholdings over several quarters, and lists ETFs that hold EXPO stock.
Exponent, Inc. Revenue Breakdown – NASDAQ:EXPO
Exponent, Inc. (NASDAQ:EXPO) generated $536.76 million USD in revenue last year. The majority of this revenue, $493.89 million USD, came from its Engineering and Other Scientific segment, with the United States being the largest regional contributor at $520.59 million USD.
Exponent Inc (EXPO) Income Statement
This article presents the quarterly and annual income statements for Exponent Inc (EXPO), providing detailed financial data from 2012 to 2026. It includes key metrics such as total revenue, operating expenses, operating profit, net income, and earnings per share, along with year-over-year percentage changes. The content is designed to offer insights into the company's financial performance and operational efficiency.
Exponent Inc (EXPO) Institutional Confidence
Exponent Inc (EXPO) has an institutional shareholding score of 10.00, ranking 1st in its industry. The institutional shareholding proportion is 99.35%, with a slight quarter-over-quarter decrease. Chuck Royce is the largest institutional shareholder with 1.31M shares, although his holdings decreased by 1.69%.
Exponent Inc (EXPO) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Exponent Inc (EXPO), highlighting its current valuation score of 6.54, which ranks 135 out of 159 in its industry. The company's P/E ratio stands at 28.49, falling below its recent high but above its recent low. Key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
Exponent Inc (EXPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Exponent Inc (EXPO), focusing on its regional revenue contributions. As of the last update on April 6, the company generated $520.59 million (89.45%) from the United States and $61.42 million (10.55%) from foreign countries. Data for business segments and profit contribution were not disclosed.
Exponent, Inc. Revenue Breakdown – FWB:EP5
Exponent, Inc. (FWB:EP5) generated 457.01 million EUR in revenue last year, with its top-performing segment, Engineering and Other Scientific, contributing 420.51 million EUR. The majority of this revenue, 443.24 million EUR, came from the United States. The company's revenue in the Engineering and Other Scientific segment increased slightly from the previous year's 453.57 million EUR.
Exponent Inc (EXPO) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Exponent Inc (EXPO), highlighting its current earnings forecast score of 8.00 and an average price target of $83.00. Based on four analysts, the stock receives a "Buy" rating, with expected revenue of $147.54 million for the next quarter and an EPS forecast of $0.55.
Exponent CEO Catherine Corrigan Sells 1,737 Shares
Exponent CEO Catherine Corrigan sold 1,737 shares of Exponent, Inc. (NASDAQ:EXPO) for $62.78 per share through a 10b5-1 trading plan. This transaction, valued at $109,045, is considered routine and partially covered an option exercise and associated taxes, with Corrigan retaining a significant stake. Despite the sale, the article highlights Exponent's stock performance, which has underperformed the S&P 500 over the last year.
CEO Catherine Corrigan Sells Shares of Exponent, Inc.
Exponent CEO Catherine Corrigan sold 1,737 shares of the company stock for $109,045 as part of a 10b5-1 trading plan, primarily to cover taxes after exercising stock options. Despite this routine transaction, Exponent's stock has underperformed the S&P 500 significantly over the past year. Analysts generally have a "Moderate Buy" rating for EXPO, although recent price target downgrades reflect some caution.
Exponent CEO Catherine Corrigan Sells 1,737 Shares
Exponent CEO Catherine Corrigan sold 1,737 shares of the company's stock for a total of $109,045. This transaction was part of a 10b5-1 trading plan and occurred after an option exercise, with a portion of the sale covering the exercise costs and taxes. Despite the sale, Corrigan retains a substantial stake in the company, though the article notes Exponent's stock has underperformed the S&P 500 over the past year.
Form 4 Exponent Inc For: 17 July By Investing.com
This article from Investing.com is a brief notice about a Form 4 filing for Exponent Inc. on July 17. It simply states the filing's existence without providing specific details about the content of the Form 4. The main body of the article appears to be primarily related to market data and unrelated trending news and stock information.
Exponent CEO Catherine Corrigan disposes of 1,737 common shares for $109,046.61
Exponent CEO Catherine Corrigan sold 1,737 common shares for $109,046.61 on July 15, 2026. This transaction followed her exercise of non-qualified stock options for 2,379 shares on the same day. After the sale, Corrigan directly held 115,771 common shares.
Exponent (NASDAQ: EXPO) CEO sells 1,737 shares after option exercise
Exponent Inc. CEO Catherine Corrigan exercised non-qualified stock options for 2,379 shares and subsequently sold 1,737 shares at $62.7776 each to cover the exercise price and taxes. These transactions, executed under a Rule 10b5-1 trading plan on July 15, 2026, left her with 115,771 direct common shares. This insider trade is considered neutral in impact and sentiment.
